Pfizer Says Its <br />Booster Provides , Protection Against Omicron Variant.<br />Pfizer Says Its <br />Booster Provides , Protection Against Omicron Variant.<br />NBC News reports officials with <br />Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant.<br />NBC News reports officials with <br />Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant.<br />Research shows their booster shot offers a similar degree of protection as two regular doses of their vaccine does against the original COVID-19 strain.<br />Three doses against Omicron are almost equivalent to the two doses effectiveness we had against the... original variant. , Albert Bourla, CEO Pfizer, via NBC News.<br />Lab tests suggest two doses of the Pfizer-BioNTech vaccine experience a 25-fold drop in efficacy when matched against the Omicron strain.<br />An independent study showed the Pfizer <br />vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies. .<br />An independent study showed the Pfizer <br />vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies. .<br />Officials say these <br />results are preliminary. <br />More data will be necessary.<br />Initially found in South Africa, the <br />heavily-mutated Omicron variant is <br />quickly spreading around the globe.<br />Initially found in South Africa, the <br />heavily-mutated Omicron variant is <br />quickly spreading around the globe.<br />Pfizer says it has begun work on an <br />Omicron-specific vaccine. According to officials it could be ready in around 100 days.<br />If we need a new vaccine, those <br />tests are telling me we will be able to have a very good <br />one if we need one. , Albert Bourla, CEO Pfizer, via NBC News.<br />The current booster will maintain protection, but if we need one, <br />we will make one and <br />we will have it by March. , Albert Bourla, CEO Pfizer, via NBC News .<br />The current booster will maintain protection, but if we need one, <br />we will make one and <br />we will have it by March. , Albert Bourla, CEO Pfizer, via NBC News
